Clinical Trials Directory

Trials / Completed

CompletedNCT05529485

Quantification of Factors Influencing Endothelial Damage During Phacoemulsification

Research and Quantification of Factors Influencing Endothelial Damage During Phacoemulsification

Status
Completed
Phase
Study type
Observational
Enrollment
121 (actual)
Sponsor
Centre Hospitalier Régional Metz-Thionville · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to determine the principal factors that influence endothelial cell loss three month post cataract surgery. Methods: Multi center observational Cohort study, inclusion period from 12/01/2022 to 10/06/2022. One hundred and seventy-five eyes of hundred and four patients who have appointment for cataract surgical indication were included. The percentage of corneal endothelial cell loss was quantified using specular microscopy before and 3 months after the surgery. 14 variables (pre-operative and intra-operative) that could be associated to endothelial cell injury were selected. A bivariate analysis of relationship between these factors and endothelial cell loss at 3 months was performed by simple linear regression (Wilcoxon and Fischer tests). Multivariate analysis was performed by multiple linear regression in order to identify the factors independently related to endothelial cell loss.

Conditions

Interventions

TypeNameDescription
PROCEDURECataract surgery by phacoemulsificationCataract surgery by phacoemulsification

Timeline

Start date
2022-01-12
Primary completion
2022-08-01
Completion
2022-08-01
First posted
2022-09-07
Last updated
2022-09-10

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05529485. Inclusion in this directory is not an endorsement.